-
Stocks mostly rise tracking earnings, US-Iran hopes
-
Alarm at German airport after drone found near Ukrainian plane, mid-air incident
-
Pakistan team reaches base camp with body of renowned climber killed in avalanche
-
Salah arrives in Turkey for Trabzonspor talks
-
Ceuta warns of 'unsustainable' situation for child migrants after influx
-
Embattled FIFA chief Infantino holds emergency talks with directors
-
SpaceX rocket stage believed to have slammed into Moon
-
Russian barrage on Kyiv kills 17 as Ukraine fails to down single missile
-
India monsoon floods, landslides kill more than 100 since July: officials
-
'Lost': Migrants despair after Britain expels them back to France
-
South Korea pro baseball league cancels games over heatwave
-
Cathay Pacific's profit soars 71% despite Iran war driving up fuel costs
-
Taiwan probes 17 China-funded firms over high-tech talent poaching
-
Russian barrage on Ukraine kills 15, wounds dozens more
-
Trump warns Iran to open Hormuz or get 'hit very hard'
-
South Korea police raid Starbucks HQ over 'Tank Day' fiasco
-
Factories shed workers in Bangladesh garment sector
-
Tech back in fashion as Asian markets extend rebound
-
North Korea warns of 'military options' over Japan rearmament
-
Total eclipse gives scientists chance to probe Sun's mysteries
-
Tiny light, big dream: Harvesting power from soil in Japan
-
What to know about the total solar eclipse on August 12
-
Trump admin to review 'closed' AI models before release: reports
-
'Like the end of the world': the eclipse chasers flocking to Spain
-
De Minaur fights past Duckworth in all-Aussie Montreal battle
-
Taiwan begins military drills as China pressure grows
-
High bills, cheap panels drive a Philippine solar surge
-
UK mansion where 'listeners' spied on Nazi generals becomes museum
-
Russian barrage on Ukraine kills 2, wounds dozens more
-
Sabalenka tops Uchijima in WTA Toronto opener
-
RE Royalties Announces Third Investment in Solaris Energy's Portfolio and Letter of Intent for Expanded Royalty Partnership for a Further US$62.7 Million
-
Alcaraz withdraws from Cincinnati Masters with wrist injury
-
Kgatlana strikes as South Africa reach WAFCON quarter-finals
-
SpaceX revenue jumps 92% in first earnings report, but shares slide
-
Pakistan close on series-levelling win against West Indies
-
US eyes Hormuz deal 'today or tomorrow' as ship sinks in Red Sea
-
Paramount CEO says politics fueling Warner Bros. merger battle
-
SpaceX revenue jumps 92% in first earnings report
-
Trump's sale of access to Truth Social raises eyebrows
-
New commissioner Berg wants to take MLS to 'next level'
-
SpaceX rocket stage expected to slam into Moon
-
Colombian ex-guerrillas fear for future under hardline president
-
US hopeful Hormuz strait deal will be done 'today or tomorrow'
-
Tsitsipas comeback continues with Montreal first-round win
-
Michigan primary puts Democratic divide on the ballot
-
Swiatek fends off Bejlek to reach Toronto third round
-
South Africa captain Kolisi to make Test return in Argentina
-
Reusser romps to overall lead at Tour de France Femmes
-
Cuba's famed resilience comes at a growing mental cost
-
McDonald's reports slower US sales in 2nd quarter
World's first malaria vaccine making inroads in western Kenya
Lucy Akinyi's three children were infected with malaria so often she would be at their local health clinic in western Kenya every other week getting them treated.
When offered the chance to protect her children with the world's first vaccine against the deadly parasitic disease, Akinyi jumped at the chance.
More than 100,000 children in malaria-endemic western Kenya have received the new vaccine against the disease, which kills 260,000 children under five every year in sub-Saharan Africa.
A pilot programme has been rolling out the groundbreaking drug -- which was 30 years in the making -- in Kenya, Ghana and Malawi since 2019.
It was approved for broad use for children in sub-Saharan Africa and other at-risk regions by the World Health Organization (WHO) in October last year.
For Akinyi and her extended family, the vaccine has worked wonders.
She would always place mosquito nets over her children while they slept, but despite her best efforts they would still get bitten outside while playing.
"We used to have a lot of malaria in our home. We could be at the hospital three times in a month," Akinyi said.
But none of her children have tested positive for malaria since being vaccinated, she said, bringing her great comfort living in a region where the disease is a major killer.
"We are very happy because none of our children are sick," Akinyi said.
Her sister-in-law, Millicent Akoth Oyoya, decided to get her own children jabbed after seeing the benefit it brought her nieces and nephews.
"When she (Akinyi) had her youngest vaccinated, that baby never got malaria," Oyoya said at a clinic as she waited to get her nine-month-old boy vaccinated in the Lake Victoria region.
"So I decided to bring mine too so that he would be malaria free."
- Game changer -
Health clinics in western Kenya -- where paediatric wards full of children sickened by malaria are not uncommon -- are starting to see results.
Admissions for malaria are falling, as is the severity of symptoms.
"Since we started administering the malaria vaccine in September 2019, we have seen a reduction of the cases of malaria," said Elsa Swerua, head nurse for malaria at Akala Health Center in Siaya County.
"Even the children who get malaria, it is not severe, and the number of deaths out of malaria has also gone down."
Less malaria -- the same person can suffer many episodes of the disease every year -- means fewer trips to the hospital, a boon for families who struggle to pay for treatment again and again.
"Before the vaccine... we would spend a lot of money on treatment and buying and going to the hospital. The cost was high," Akinyi said.
Now, there is more money to go around for food and other essentials, she said.
Dr Simon Kariuki, chief research officer at the Kenya Medical Research Institute, and a leading expert on malaria, said the vaccine was a game changer.
"We showed that this vaccine is safe, and can be given to young African children who bare the higher burden of malaria," he said.
The pilot trial had shown the vaccine could "reduce malaria incidents in young children in these areas by almost 40 percent", he said.
The WHO has recommended that the vaccine be administered in a four-dose regimen for children from five months of age in areas with moderate to high transmission of malaria.
L.Mesquita--PC